Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); 2012 Preview - PCI-32765 Transitioning to Phase 3
Go back to Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); 2012 Preview - PCI-32765 Transitioning to Phase 3| Johnson & Johnson (NYSE: JNJ) | Delayed: 260.35 -1.73 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.08 | 52 Week High | $126.07 | |||
| Open | $260.65 | 52 Week Low | $94.28 | |||
| Day High | $261.71 | P/E | 54.13 | |||
| Day Low | $259.16 | EPS | $4.81 | |||
| Volume | 4,998,268 | |||||
| Pharmacyclics, Inc. (NASDAQ: PCYC) | Delayed: 261.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.25 | 52 Week High | $261.68 | |||
| Open | $0.82 | 52 Week Low | $85.50 | |||
| Day High | $261.25 | P/E | 300.29 | |||
| Day Low | $261.25 | EPS | $0.87 | |||
| Volume | 3,226 | |||||
